Back to Markets
Stocks● Neutral
Century Health Raises $5M to Scale AI Clinical Data Platform
Century Health closes $5M seed round led by Origin Ventures to automate clinical data curation. The raise signals growing investor appetite for AI-powered real-world evidence platforms in specialty medicine.
Continue with
Century Health, a New York-based health technology company, closed an oversubscribed $5 million seed round led by Origin Ventures. The round included new investors InnovateHealth Ventures, 25madison, and Next Play Ventures, along with returning backers 2048 Ventures and Alumni Ventures. Strategic angel investors include Zorba Lieberman, founder of Citeline, and clinicians from nephrology, neurology, and ophthalmology.
The company applies AI to real-world clinical data to automate data curation and enrichment, replacing manual data entry while maintaining patient privacy. The fresh capital will go toward scaling collaborations with pharmaceutical and life sciences partners, expanding its specialty provider data network, and building out its AI-powered infrastructure.
Why Century Health's $5M Raise Matters
The naive read is another seed-stage health AI company taking money. The better market read is that real-world evidence (RWE) generation remains a pain point that pharma is willing to pay to solve. Clinical data sits in fragmented silos across electronic health records, labs, and specialty practices. Extracting usable, structured datasets for research typically requires manual abstraction – slow, expensive, and error-prone.
Century Health’s platform tackles that bottleneck at the curation layer. By automating the process, it can deliver higher-quality datasets faster. The oversubscribed round and the specific clinical expertise among angel investors suggest the company already has early traction with partners in nephrology, neurology, and ophthalmology – verticals where longitudinal real-world data is especially valuable for drug development and post-market surveillance.